Chronic Kidney Disease(CKD)NCT06683339
Functional Capacity in Children with Chronic Kidney Disease
An observational study of Chronic Kidney Disease(CKD), run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
The aim of our study is to assess the functional capacity of children with chronic kidney disease using various tests. Read more about this study
- Who is it for?
- Ages 6 to 18 years
- Conditions the study is for
- Chronic Kidney Disease(CKD)
- How many people
- 26 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 16 May 2022to Jun 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Children with chronic kidney disease will be included in the study.
Who may be able to join
- Having been diagnosed with chronic kidney disease
- Being clinically stable
- Being between 6-18 years old
- Volunteering to participate in the research
Who cannot join
- Having a musculoskelatal disease that may affect functional capacity measurement
- Having a cognitive problem
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Hacettepe University
Ankara
Naciye Vardar-Yagli, +90 312 305 15 76, naciyevardar@yahoo.com
About this study
Official title: Assessment of Functional Capacity in Children with Chronic Kidney Disease
The aim of our study is to assess the functional capacity of children with chronic kidney disease using various tests.
- Conditions
- Chronic Kidney Disease(CKD)
- Medical subject headings
- Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Children with chronic kidney disease | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise capacity
Exercise capacity will be evaluated with 6 minute walk test.
Measured: 1st day
Exercise capacity
Exercise capacity will be assessed using 2 minute walk test
Measured: 1st day
Exercise capacity
Exercise capacity will be assessed using 3 minute step test.
Measured: 1st day
Secondary outcomes (1)
Muscle strength
Knee extensor and hand grip strength will be measured using a hand dynamometer.
Measured: 1st day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Nov 2024
- Study start16 May 2022
- Primary completionDec 2024 (estimated)
- Study completionJun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Chronic Kidney Disease(CKD)Studies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 26 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Firat, Kirsehir Ahi Evran Universitesi
- Investigators
- Merve Firat, Principal investigator, Kirsehir Ahi Evran UniversitesiNaciye Vardar-Yagli, Study director, Hacettepe UniversityBora Gulhan, Study chair, Hacettepe UniversityMelda Saglam, Study chair, Hacettepe UniversityAydan Asli Aksel-Uylar, Study chair, Hacettepe UniversityRezan Topaloglu, Study chair, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06683339
- Sponsor's protocol ID
- 2022/04-27
- Status last verified
- Nov 2024
- First submitted
- 8 Nov 2024
- Last updated
- 26 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Firat M, Aksel-Uylar AA, Saglam M, Topaloglu R, Ozaltin F, Duzova A, Vardar-Yagli N, Gulhan B. Assessment of functional capacity in children with chronic kidney disease using various field tests. Pediatr Nephrol. 2026 May 11. doi: 10.1007/s00467-026-07306-6. Online ahead of print.
PubMed 42113273
Study at a glance
From the registry record, last updated by the sponsor on 26 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Functional Capacity in Children with Chronic Kidney Disease
- ClinicalTrials.gov ID
- NCT06683339
- Acronym / sponsor ID
- 2022/04-27
- Conditions
- Chronic Kidney Disease(CKD)
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 26 participants (estimated)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 16 May 2022 (actual)
- Primary completion
- Dec 2024 (estimated)
- Study completion
- Jun 2025 (estimated)
- First posted
- 12 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of our study is to assess the functional capacity of children with chronic kidney disease using various tests.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Children with chronic kidney disease | – | – |
Who may qualify
- Ages
- 6 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Children with chronic kidney disease will be included in the study.
Key inclusion criteria (4 listed)
- Having been diagnosed with chronic kidney disease
- Being clinically stable
- Being between 6-18 years old
- Volunteering to participate in the research
Key exclusion criteria (2 listed)
- Having a musculoskelatal disease that may affect functional capacity measurement
- Having a cognitive problem
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Exercise capacity
Time frame: 1st day
Exercise capacity will be evaluated with 6 minute walk test.
Exercise capacity
Time frame: 1st day
Exercise capacity will be assessed using 2 minute walk test
Exercise capacity
Time frame: 1st day
Exercise capacity will be assessed using 3 minute step test.
1 secondary outcome
Muscle strength
Time frame: 1st day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Nov 2024.
- Derived from this study: PubMed 42113273Firat M, Aksel-Uylar AA, Saglam M, Topaloglu R, Ozaltin F, Duzova A, Vardar-Yagli N, Gulhan B. Assessment of functional capacity in children with chronic kidney disease using various field tests. Pediatr Nephrol. 2026 May 11. doi: 10.1007/s00467-026-07306-6. Online ahead of print.
Related trials for Chronic Kidney Disease(CKD)
RecruitingObservational study
Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors
Chronic Kidney Disease
Active, not recruitingObservational study
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
Chronic Kidney Disease, Type 2 Diabetes Mellitus
RecruitingObservational study
Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Cardiovascular Diseases, Kidney Transplant; Complications
Not yet recruiting
Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis
Intradialytic Nausea and Vomiting, Chronic Kidney Disease
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Chronic Kidney Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Merve Firat principal investigator
Kirsehir Ahi Evran Universitesi
Naciye Vardar-Yagli study director
Hacettepe University
Bora Gulhan study chair
Hacettepe University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Kidney Disease(CKD), run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Naciye Vardar-Yagli (+903123051576, naciyevardar@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise capacity (time frame: 1st day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06683339, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2024.